Bicycle Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.15; its P/E ratio is -4.40; Bicycle Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-1.25. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 5.33M	$ 5.35M	$ 11.40M	$ 4.90M	$ 3.19M
Gross Profit	$ 5.33M	$ 5.35M	$ 11.40M	$ 4.90M	$ 3.19M
EBIT	$ -47.96M	$ -46.81M	$ -42.30M	$ -38.87M	$ -32.21M
EBITDA	$ -46.30M	$ -45.12M	$ -40.65M	$ -37.32M	$ -30.82M
Net Income Common Stockholders	$ -49.10M	$ -49.93M	$ -42.60M	$ -39.08M	$ -29.90M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 526.40M	$ 572.10M	$ 340.40M	$ 293.80M	$ 339.20M
Total Assets	$ 595.34M	$ 638.68M	$ 454.14M	$ 428.80M	$ 410.65M
Total Debt	$ 40.08M	$ 41.03M	$ 42.39M	$ 44.81M	$ 41.20M
Net Debt	$ -486.32M	$ -531.07M	$ -298.01M	$ -248.99M	$ -298.00M
Total Liabilities	$ 224.41M	$ 222.66M	$ 234.07M	$ 185.64M	$ 410.61M
Stockholders Equity	$ 370.93M	$ 416.02M	$ 220.06M	$ 243.16M	$ 270.78M
Cash Flow	-
Free Cash Flow	$ -47.34M	$ -1.53M	$ 33.82M	$ -48.51M	$ -31.76M
Operating Cash Flow	$ -47.29M	$ -1.02M	$ 34.10M	$ -46.41M	$ -30.31M
Investing Cash Flow	$ -51.00K	$ -502.00K	$ -277.00K	$ -2.10M	$ -1.45M
Financing Cash Flow	$ 386.00K	$ 234.63M	$ 12.29M	$ 2.72M	$ 5.89M

Currency in USD

Bicycle Therapeutics Earnings and Revenue History

Income Statement >

Bicycle Therapeutics Debt to Assets

Balance Sheet >

Bicycle Therapeutics Cash Flow

Cash Flow >

Bicycle Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing